Ihab Hamzeh

Ihab Hamzeh

Auto-generated profile, based on publicly available information

Ihab Hamzeh

Section of Cardiology, Department of Internal Medicine, Baylor College of Medicine, Houston, Tex

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2019 in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
MKMahin R. Khan
Mahin R. Khan
WKWaleed T. Kayani
Waleed T. Kayani
WAWaqas Ahmad
Waqas Ahmad
MMMalalai Manan
Malalai Manan
RHRavi S. Hira
Ravi S. Hira
MAMahboob Alam
Mahboob Alam
Background: Older adults (≥70‐year‐old) are under‐represented in the published data pertaining to unprotected left main coronary artery disease (ULMCAD). Hypothesis: Percutaneous coronary intervention (PCI) might be comparable to coronary artery bypass grafting (CABG) for revascularization of ULMCAD.Methods: We compared PCI versus CABG in older adults with ULMCAD with an aggregate data meta‐analyses (4880 patients) of clinical outcomes [all‐cause mortality, myocardial infarction (MI), repeat revascularization, stroke and major adverse cardiac and cerebrovascular events(MACCE)] at 30 days, 12‐24 months & ≥36 months in patients with mean age ≥70 years and ULMCAD. A meta‐regression analysis evaluated the effect of age on mortality after PCI. Odds ratios (OR) and 95% confidence intervals (CI) were estimated using random‐effects model.Results: All‐cause mortality between PCI and CABG was comparable at 30‐days (OR0.77, 95% CI 0.42‐ 1.41) and 12‐24‐months (OR 1.22, 95% CI 0.78‐1.93). PCI was associated with a markedly lower rate of stroke at 30‐day follow‐up in octogenarians (OR 0.14, 95% CI 0.02‐0.76) but an overall higher rate of repeat revascularization. At ≥36‐months, MACCE (OR 1.26,95% CI 0.99‐1.60) and all‐cause mortality (OR 1.39, 95% CI 1.00‐1.93) showed a trend favoring CABG but did not reach statistical significance. On meta‐regression, PCI was associated with a higher mortality with advancing age (coefficient=0.1033, p=0.042).Conclusions: PCI was associated with a markedly lower rate of early stroke in octogenarians as compared to CABG. All‐cause mortality was comparable between the two arms with a trend favoring CABG at ≥36‐months.PCI was however associated with increasing mortality with advancing age as compared to CABG.

1 March 2021 in The American Journal of Cardiology
Verified
Journal Article
Closed access
WUWaqas Ullah
Waqas Ullah
SZSalman Zahid
Salman Zahid
IHIhab Hamzeh
Ihab Hamzeh
Yochai BirnbaumYochai Birnbaum
Yochai Birnbaum
SPSalim S Virani MD, PhD
Salim S Virani MD, PhD
MAMahboob Alam
Mahboob Alam

1 April 2020 in Cardiovascular Diagnosis and Therapy
Verified
Journal Article
Open access
PDF file
MKMahin R. Khan
Mahin R. Khan
WKWaleed T. Kayani
Waleed T. Kayani
MMMalalai Manan
Malalai Manan
AMAhmad Munir
Ahmad Munir
IHIhab Hamzeh
Ihab Hamzeh
MAMahboob Alam
Mahboob Alam
Background: To compare safety and efficacy of transcatheter aortic valve replacement (TAVR) with surgical aortic valve replacement (SAVR) in patients at low-intermediate risk, given the paucity of robust data. Methods: We performed an aggregate data meta-analysis of 7 randomized controlled trials (RCTs) and 6,778 patients comparing TAVR with SAVR for aortic stenosis (AS) in low-intermediate risk patients (Society of Thoracic Surgeons risk-score ≤8%) using the random-effects model. Primary outcome was all-cause mortality at 30-day, 1-year and 2-year of follow-up. Secondary outcomes included cardiac-mortality, stroke, acute kidney injury (AKI), atrial fibrillation (AF), permanent pacemaker (PPM) implantation, major-bleeding, moderate-severe paravalvular regurgitation (PVR) and rehospitalization. Results: All-cause mortality, cardiac-mortality and stroke were comparable between the two groups. AF was higher with SAVR at 30-day [odds ratio (OR) 0.17, 95% confidence intervals (CI): 0.12–0.24] thorough to 2-year (OR 0.34, 95% CI: 0.21–0.55), while PPM implantation was higher with TAVR (30-day: OR 3.31, 95% CI: 1.64–6.66, 2-year: OR 3.17, 95% CI: 1.02–9.86). Moderate-severe PVR was more prevalent with TAVR at all follow-ups. On inter-group comparison, patients in the low-risk group had an even lower risk of AF, but a higher risk of PPM implantation as compared to the patients in the intermediate-risk group undergoing TAVR. Conclusions: Compared to SAVR, TAVR had comparable all-cause mortality and stroke, lower-risk of AF, but was associated with a higher risk of PPM implantation and moderate-severe PVR in low-intermediate-risk patients. Thus, highlighting the need for longer-term follow-up before robust inferences are drawn.

1 August 2020 in The American Journal of Medicine
Verified
Journal Article
Closed access
DSDeepthi Sudhakar
Deepthi Sudhakar
HKHassan Kamran
Hassan Kamran
NCNan Chen
Nan Chen
MMMartha Mims
Martha Mims
IHIhab Hamzeh
Ihab Hamzeh

20 November 2021 in The American Journal of Medicine
Verified
Journal Article
Closed access
SKSeulgi E. Kim
Seulgi E. Kim
SKStephanie Koh
Stephanie Koh
IHIhab Hamzeh
Ihab Hamzeh

1 May 2021 in JACC
Verified
Journal Article
Closed access
WUWaqas Ullah
Waqas Ullah
NTNishanth Thalambedu
Nishanth Thalambedu
SZSalman Zahid
Salman Zahid
SSSameer Saleem
Sameer Saleem
DJDrew Johnson
Drew Johnson
MAMahboob Alam
Mahboob Alam